Emotional Brain is an independent  scientific research company, based in Almere (the Netherlands) and New York (US). We have a broad IP portfolio based on unique expertise in the causes of and pharmaceutical treatments for Female Sexual Dysfunction (FSD).

Our ambition is to develop innovative products and tools in the field of FSD. To reach a more individualized approach in drug development and healthcare, Emotional Brain distinguishes herself by using subgroup focused research techniques.

Our core business consists of the development of two new drugs  for the treatment of one of the FSD subtypes: Hypoactive Sexual Desire Disorder (HSDD), which is characterized by chronic or recurrent loss or decrease in interest in sexual activity, causing sexual dissatisfaction and severely affecting a woman’s quality of life.